AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $16.13 +1.77%
Financial Fact:
Sales and marketing: 19.49M
Today's EPS Names:
RIBT, INLB, FTXP, More
Financial Fact:
Sales and marketing: 19.49M
Today's EPS Names:
RIBT, INLB, FTXP, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q4 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $86.61 million versus the consensus estimate of $80.24 million.
GUIDANCE:
AngioDynamics sees FY2027 EPS of ($0.29)-$0.24, versus the consensus of ($0.20). AngioDynamics sees FY2027 revenue of $336-341 million, versus the consensus of $314 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
- Lobe Sciences closes $2.16M private placement for S-100 drug program
- Morgan Stanley Upgrades Robinhood Markets (HOOD) to Overweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
